Targeted microRNA Profiling in Gastric Cancer with Clinical Assessement
By:
References
- National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology Gastric Cancer (Version 2.2020). [Accessed July 7, 2020]. Available at: http://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf.
- Strand MS, Lockhart AC, Fields RC. Genetics of gastric cancer. Surg Clin North Am. 2017; 97(2): 345–370.
- Wang Q, Liu G, Hu C. Molecular classification of gastric adenocarcinoma. Gastroenterology Res. 2019; 12(6): 275–282.
- Jansson MD, Lund AH. MicroRNA and cancer. Mol Oncol. 2012; 6(6): 590–610.
- Price C, Chen J. MicroRNAs in cancer biology and therapy: Current status and perspectives. Genes Dis. 2014; 1(1): 53–63.
- Yang Z, Wu L, Wang A, Tang W, Zhao Y, Zhao H, et al. DbDEMC 2.0: Updated database of differentially expressed miRNAs in human cancers. Nucleic Acids Res. 2017; 45(D1): D812–D818.
- East Carolina University, Greenville, NC, USA. microRNA Cancer Association Database. Published 2020. [Accessed February 18 2019]. Available at: http://mircancer.ecu.edu/index.jsp.
- National Center for Biotechnology Information (NCBI). DNA and RNA databases. Published 2019. [Accessed July 7 2020] Available at: https://www.ncbi.nlm.nih.gov/.
- Morata-Tarifa C, Picon-Ruiz M, Griñan-Lison C, Boulaiz H, Perán M, Garcia MA, et al. Validation of suitable normalizers for miR expression patterns analysis covering tumour heterogeneity. Sci Rep. 2017; 7: 39782.
- Tsukamoto Y, Nakada C, Noguchi T, Tanigawa M, Nguyen LT, Uchida T, et al. MicroRNA-375 is down-regulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res. 2010; 70(6): 2339–2349.
- Ding L, Xu Y, Zhang W, Deng Y, Si M, Du Y, et al. MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res. 2010; 20(7): 784–793.
- Shen Z-Y, Zhang Z-Z, Liu H, Zhao E-H, Cao H. miR-375 inhibits the proliferation of gastric cancer cells by repressing ERBB2 expression. Exp Ther Med. 2014; 7(6): 1757–1761.
- Sakamoto N, Naito Y, Oue N, Sentani K, Uraoka N, Oz HZ, et al. MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis. Cancer Sci. 2014; 105(2): 236–243.
- Zheng G, Xiong Y, Xu W, Wang Y, Chen F, Wang Z, et al. A two-microRNA signature as a potential biomarker for early gastric cancer. Oncol Lett. 2014; 7(3): 679–684.
- Zheng B, Liang L, Wang C, Huang S, Cao X, Zha R, et al. MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer. Clin Cancer Res. 2011; 17(24): 7574–7583.
- Tu L, Zhao E, Zhao W, Zhang Z, Tang D, Zhang Y, et al. hsa-miR-376c-3p regulates gastric tumor growth both in vitro and in vivo. BioMed Res Int. 2016; 2016: 1–7.
- Hung P-S, Chen C-Y, Chen W-T, Kuo C-Y, Fang W-L, Huang KH, et al. miR-376c promotes carcinogenesis and serves as a plasma marker for gastric carcinoma. PLos One. 2017; 12(5): e0177346.
- Yu X, Song H, Xia T, Han S, Xiao B, Luo L, et al. Growth inhibitory effects of three miR-129 family members on gastric cancer. Gene. 2013; 532(1): 87–93.
- Xu C, Shao Y, Xia T, Yang Y, Dai J, Luo L, et al. lncRNA-AC130710 targeting by miR-129-5p is up-regulated in gastric cancer and associates with poor prognosis. Tumor Biol. 2014; 35(10): 9701–9706.
- Wu H, Huang M, Lu M, Zhu W, Shu Y, Cao P, et al. Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel. Cancer Chemother Pharmacol. 2013; 71(5): 1159–1171.
- Oh H-K, Tan AL-k, Das K, Ooi C-H, Deng N-T, Tan IB, et al. Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer. Clin Cancer Res. 2011; 17(9): 2657–2667.
- Geng H, Li K, Pan Q, Tao S, Li C, Zhao H, et al. Identification and expression of several circular RNAs and knockdown of hsa_circ_0005556 exerts oncogenic functions by miR-767-5p in gastric cancer. Med Sci Monit. 2020; 26: e921163.
- Bradburn S. How to perform the delta-delta Ct method? [Accessed July 7 2020] Available at: https://toptipbio.com/delta-delta-ct-pcr/.
- Wickham H. ggplot2: Elegant Graphics for Data Analysis. New York, NY, USA: Springer-Verlag, 2016. Retrieved from https://ggplot2.tidyverse.org.
- Brierley J, Gospodarowicz MK, Wittekind CH, Editors. TNM Classification of Malignant Tumours, 8th ed. Oxford, Oxon, UK; John Wiley & Sons, Inc.; 2017.
- Sexton RE, Al Hallak MN, Diab M, Azmi AS. Gastric cancer: A comprehensive review of current and future treatment strategies. Cancer Metastasis Rev. 2020; 39(4): 1179–1203.
- Link A, Kupcinskas J. MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives. World J Gastroenterol. 2018; 24(30): 3313–3329.
- Li Z, Liu Z-M, Xu B-H. A meta-analysis of the effect of microRNA-34a on the progression and prognosis of gastric cancer. Eur Rev Med Pharmacol Sci. 2018; 22(23): 8281–8287.
- Wang Q-X, Zhu Y-Q, Zhang H, Xiao J. Altered miRNA expression in gastric cancer: A systematic review and meta-analysis. Cell Physiol Biochem. 2015; 35(3): 933–944.
- Ben-Dayan MM, MacCarthy T, Schlecht NF, Belbin TJ, Childs G, Smith RV, et al. Cancer as the disintegration of robustness: Population-level variance in gene expression identifies key differences between tobacco- and HPV-associated oropharyngeal carcinogenesis. Arch Pathol Lab Med.. 2015; 139(11): 1362–1372.
- Hooten NN, Fitzpatrick M, Wood WH 3rd, De S, Ejiogu N, Zhang Y, et al. Age-related changes in micro-RNA levels in serum. Aging (Albany NY). 2013; 5(10): 725–740.
- Cui S, Zhang K, Li C, Chen J, Pan Y, Feng B, et al. Methylation-associated silencing of microRNA-129-3p promotes epithelial-mesenchymal transition, invasion and metastasis of hepatocelluar cancer by targeting Aurora-A. Oncotarget. 2016; 7(47): 78009–78028.
- Xu Y, Deng Y, Yan X, Zhou T. Targeting miR-375 in gastric cancer. Expert Opin Ther Targets. 2011; 15(8): 961–972.
- Bhatti I, Lee A, James V, Hall RI, Lund JN, Tufarelli C, et al. Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma. J Gastrointest Surg. 2011; 15(1): 199–208.
- Yu L, Todd NW, Xing L, Xie Y, Zhang H, Liu Z, et al. Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers. Int J Cancer. 2010; 127(12): 2870–2878.
- Yan X-L, Luo Q-Y, Zhou S-N, Pan W-T, Zhang L, Yang D-J, et al. MicroRNA-375 reverses the expression of PD-L1 by inactivating the JAK2/STAT3 signaling pathways in gastric cancer. Clin Res Hepatol Gastroenterol. 2021; 45(5): 101574.
- Lian S, Park J, Xia Y, Nguyen TT, Joo YE, Kim KK, et al. MicroRNA-375 functions as a tumor-suppressor gene in gastric cancer by targeting Recepteur d’Origine Nantais. Int J Mol Sci. 2016; 17(10): 1633.
- Ni H, Qin H, Sun C, Liu Y, Ruan G, Guo Q, et al. MiR-375 reduces the stemness of gastric cancer cells through triggering ferroptosis. Stem Cell Res Ther. 2021; 12(1): 325.
- Xia J, Guo X, Yan J, Deng K. The role of miR-148a in gastric cancer. J Cancer Res Clin Oncol. 2014; 140(9): 1451–1456.
- Yu B, Lv X, Su L, Li J, Yu Y, Gu Q, et al. MiR-148a functions as a tumor suppressor by targeting CCKBR via inactivating STAT3 and Akt in human gastric cancer. PLoS One. 2016; 11(8): e0158961.
- Mu Y-P, Tang S, Sun W-J, Gao W-M, Wang M, Su X-L. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer. Asian Pac J Cancer Prev. 2014; 15(20): 8893–8900.
- Chen C, Zhang Y, Zhang L, Weakley SM, Yao Q. MicroRNA-196: Critical roles and clinical applications in development and cancer. J Cell Mol Med. 2011; 15(1): 14–23.
- Skrzypski M, Czapiewski P, Goryca K, Jassem E, Wrywicz L, Pawlowski R, et al. Prognostic value of microRNA expression in operable non-small cell lung cancer patients. Br J Cancer. 2014; 110(4): 991–1000.
- Filipska M, Skrzypski M, Czetyrbok K, Stokowy T, Stasilojc G, Supernat A, et al. MiR-192 and miR-662 enhance chemoresistance and invasiveness of squamous cell lung carcinoma. Lung Cancer. 2018; 118: 111–118.
- Loriot A, Van Tongelen A, Blanco J, Klaessens S, Cannuyer J, Van Baren N, et al. A novel cancer-germline transcript carrying pro-metastatic miR-105 and TET-targeting miR-767 induced by DNA hypomethylation in tumors. Epigenetics. 2014; 9(8): 1163–1171.
- Zhang K, Guo L. MiR-767 promoted cell proliferation in human melanoma by suppressing CYLD expression. Gene. 2018; 641: 272–278.
- Feng Y, Zhang L, Wu J, Khadka B, Fang Z, Gu J, et al. CircRNA circ_0000190 inhibits the progression of multiple myeloma through modulating miR-767-5p/MAPK4 pathway. J Exp Clin Cancer Res. 2019; 38(1): 54.
- Liu H, Wu Y, Wang S, Jiang J, Zhang C, Jiang Y, et al. Circ-SMARCA5 suppresses progression of multiple myeloma by targeting miR-767-5p. BMC Cancer. 2019; 19(1): 937.
- Zhang L, Geng Z, Wan Y, Meng F, Meng X, Wang L. Functional analysis of miR-767-5p during the progression of hepatocellular carcinoma and the clinical relevance of its dysregulation. Histochem Cell Biol. 2020; 154(2): 231–243.
- Xiang Z, Xu C, Wu G, Liu B, Wu D. CircRNA-UCK2 increased TET1 inhibits proliferation and invasion of prostate cancer cells via sponge miRNA-767-5p. Open Med (Wars). 2019; 14(1): 833–842.
- Zhang J, Xu S, Xu J, Li Y, Zhang J, Zhang J, et al. miR 767 5p inhibits glioma proliferation and metastasis by targeting SUZ12. Oncol Rep. 2019; 42(1): 55–66.
DOI: https://doi.org/10.2478/bjmg-2021-0022 | Journal eISSN: 2199-5761
Language: English
Page range: 55 - 64
Published on: Jun 5, 2022
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2022 H Pehlevan Özel, T Dinç, RS Tiryaki, AG Keşküş, Ö Konu, SI Kayilioğlu, F Coşkun, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.